{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:53Z","timestamp":1793134133048,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Breast Cancer Research Institute, Ireland."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11845-022-03157-w","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T11:03:52Z","timestamp":1663326232000},"page":"1595-1600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Oncological safety of active surveillance for low-risk ductal carcinoma in situ \u2014 a systematic review and meta-analysis"],"prefix":"10.1007","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9892-9920","authenticated-orcid":false,"given":"Matthew G.","family":"Davey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife J.","family":"Lowery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Kerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"3157_CR1","doi-asserted-by":"crossref","unstructured":"Virnig BA et al (2010) Ductal carcinoma in situ: risk factors and impact of screening. J Nat Cancer Inst Monogra 2010(41):113\u2013116","DOI":"10.1093\/jncimonographs\/lgq024"},{"issue":"4","key":"3157_CR2","doi-asserted-by":"publisher","first-page":"912","DOI":"10.2214\/AJR.20.23314","volume":"216","author":"CH Neal","year":"2021","unstructured":"Neal CH et al (2021) Digital mammography has persistently increased high-grade and overall DCIS detection without altering upgrade rate. AJR Am J Roentgenol 216(4):912\u2013918","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"3157_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3157_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12262-013-0987-0","volume":"77","author":"Y Vaidya","year":"2015","unstructured":"Vaidya Y, Vaidya P, Vaidya T (2015) Ductal carcinoma in situ of the breast. Indian J Surg 77(2):141\u2013146","journal-title":"Indian J Surg"},{"issue":"5","key":"3157_CR5","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/SLA.0000000000002239","volume":"267","author":"LE Elshof","year":"2018","unstructured":"Elshof LE et al (2018) Cause-specific mortality in a population-based cohort of 9799 women treated for ductal carcinoma in situ. Ann Surg 267(5):952\u2013958","journal-title":"Ann Surg"},{"key":"3157_CR6","doi-asserted-by":"crossref","unstructured":"Worni M et al (2015) Trends in treatment patterns and outcomes for ductal carcinoma in situ. J Natl Cancer Inst\u00a0107(12):djv263","DOI":"10.1093\/jnci\/djv263"},{"issue":"4","key":"3157_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","volume":"121","author":"M van Seijen","year":"2019","unstructured":"van Seijen M et al (2019) Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer 121(4):285\u2013292","journal-title":"Br J Cancer"},{"key":"3157_CR8","doi-asserted-by":"crossref","unstructured":"Davey MG et al (2022) Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis. BJS Open\u00a06(2)","DOI":"10.1093\/bjsopen\/zrac022"},{"issue":"1","key":"3157_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1677\/erc.0.0080047","volume":"8","author":"DC Allred","year":"2001","unstructured":"Allred DC, Mohsin SK, Fuqua SA (2001) Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 8(1):47\u201361","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"3157_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10549-011-1430-5","volume":"129","author":"EM Ozanne","year":"2011","unstructured":"Ozanne EM et al (2011) Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat 129(1):165\u2013173","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"3157_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10911-018-9415-1","volume":"23","author":"K Doke","year":"2018","unstructured":"Doke K, Butler S, Mitchell MP (2018) Current therapeutic approaches to DCIS. J Mammary Gland Biol Neoplasia 23(4):279\u2013291","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"20","key":"3157_CR12","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1200\/JCO.19.02888","volume":"38","author":"ES Hwang","year":"2020","unstructured":"Hwang ES, Solin L (2020) De-escalation of locoregional therapy in low-risk disease for DCIS and early-stage invasive cancer. J Clin Oncol 38(20):2230\u20132239","journal-title":"J Clin Oncol"},{"issue":"16","key":"3157_CR13","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis A et al (2015) Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer 51(16):2296\u20132303","journal-title":"Eur J Cancer"},{"issue":"12","key":"3157_CR14","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","volume":"51","author":"LE Elshof","year":"2015","unstructured":"Elshof LE et al (2015) Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ \u2013 the LORD study. Eur J Cancer 51(12):1497\u20131510","journal-title":"Eur J Cancer"},{"issue":"3","key":"3157_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang ES et al (2019) The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open 9(3):e026797","journal-title":"BMJ Open"},{"key":"3157_CR16","doi-asserted-by":"crossref","unstructured":"Kanbayashi C et al (2019) The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA). J Clin Oncol\u00a037(15_suppl):TPS603\u2013TPS603","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS603"},{"key":"3157_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535","journal-title":"BMJ"},{"key":"3157_CR18","doi-asserted-by":"crossref","unstructured":"Stroup DF et al (2008) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008\u20132012","DOI":"10.1001\/jama.283.15.2008"},{"issue":"9","key":"3157_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603\u2013605","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"3157_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5395\/rde.2017.42.2.152","volume":"42","author":"H-Y Kim","year":"2017","unstructured":"Kim H-Y (2017) Statistical notes for clinical researchers: chi-squared test and Fisher\u2019s exact test. Restor Dent Endod 42(2):152\u2013155","journal-title":"Restorative dentistry & endodontics"},{"issue":"1","key":"3157_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.clon.2020.07.007","volume":"33","author":"M Co","year":"2021","unstructured":"Co M et al (2021) Long-term survival outcomes of \u201clow risk\u201d ductal carcinoma in situ from a territory-wide cancer registry. Clin Oncol (R Coll Radiol) 33(1):40\u201345","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"11","key":"3157_CR22","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.acra.2017.05.017","volume":"24","author":"LJ Grimm","year":"2017","unstructured":"Grimm LJ et al (2017) Imaging features of patients undergoing active surveillance for ductal carcinoma in situ. Acad Radiol 24(11):1364\u20131371","journal-title":"Acad Radiol"},{"issue":"11","key":"3157_CR23","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.1245\/s10434-021-09870-7","volume":"28","author":"J Limberg","year":"2021","unstructured":"Limberg J et al (2021) Intraductal papilloma of the breast: prevalence of malignancy and natural history under active surveillance. Ann Surg Oncol 28(11):6032\u20136040","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"3157_CR24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamasurg.2015.0876","volume":"150","author":"Y Sagara","year":"2015","unstructured":"Sagara Y et al (2015) Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA Surg 150(8):739\u2013745","journal-title":"JAMA Surg"},{"issue":"3","key":"3157_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/tbj.12889","volume":"24","author":"PK Garg","year":"2018","unstructured":"Garg PK et al (2018) Adjuvant radiotherapy versus observation following lumpectomy in ductal carcinoma in-situ: a meta-analysis of randomized controlled trials. Breast J 24(3):233\u2013239","journal-title":"Breast J"},{"issue":"41","key":"3157_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","volume":"2010","author":"C Correa","year":"2010","unstructured":"Correa C et al (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010(41):162\u2013177","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"3157_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.21037\/tau.2017.12.24","volume":"7","author":"N Kinsella","year":"2018","unstructured":"Kinsella N et al (2018) Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices. Transl Androl Urol 7(1):83\u201397","journal-title":"Transl Androl Urol"},{"issue":"2","key":"3157_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jamaoncol.2019.4849","volume":"6","author":"M Morrow","year":"2020","unstructured":"Morrow M, Winer EP (2020) De-escalating breast cancer surgery\u2014where is the tipping point? JAMA Oncol 6(2):183\u2013184","journal-title":"JAMA Oncol"},{"issue":"10","key":"3157_CR29","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318(10):918\u2013926","journal-title":"JAMA"},{"issue":"Suppl 1","key":"3157_CR30","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.breast.2017.06.018","volume":"34","author":"M Morrow","year":"2017","unstructured":"Morrow M (2017) De-escalating and escalating surgery in the management of early breast cancer. Breast 34(Suppl 1):S1-S4","journal-title":"Breast"},{"key":"3157_CR31","doi-asserted-by":"crossref","first-page":"117822342110222","DOI":"10.1177\/11782234211022203","volume":"15","author":"MG Davey","year":"2021","unstructured":"Davey MG et al (2021) Evaluating the clinical utility of routine sentinel lymph node biopsy and the value of adjuvant chemotherapy in elderly patients diagnosed with oestrogen receptor positive, clinically node negative breast cancer. Breast Cancer (Auckl) 15:11782234211022204","journal-title":"Breast Cancer (Auckl)"},{"key":"3157_CR32","doi-asserted-by":"crossref","unstructured":"de Paz Villanueva CC\u00a0et al (2017) Factors associated with underestimation of invasive cancer in patients with ductal carcinoma in situ: precautions for active surveillance. JAMA Surg\u00a0152(11):1007\u20131014","DOI":"10.1001\/jamasurg.2017.2181"},{"key":"3157_CR33","doi-asserted-by":"crossref","unstructured":"Zheng L, G\u00f6kmen-Polar Y, Badve SS (2022)\u00a0Is conservative management of ductal carcinoma in situ risky?\u00a0NPJ Breast Cancer\u00a08(1):55","DOI":"10.1038\/s41523-022-00420-2"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-03157-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-022-03157-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-03157-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T10:17:49Z","timestamp":1690798669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-022-03157-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3157"],"URL":"https:\/\/doi.org\/10.1007\/s11845-022-03157-w","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"28 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required as this is a systematic review of previously published studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not required as this is a review of previously published data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}